Lataa...

Basal–Prandial Insulin Delivery in Type 2 Diabetes Mellitus via the V-Go™: A Novel Continuous Subcutaneous Infusion Device

BACKGROUND: The V-Go™ is a once-daily disposable device that allows coverage of basal and prandial insulin requirements over a period of 24 hours. The aim of this proof-of-concept study was to evaluate the clinical functionality, safety, and pharmacodynamics of the V-Go delivering insulin aspart and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kapitza, Christoph, Fein, Seymour, Heinemann, Lutz, Schleusener, Debra, Levesque, Steven, Strange, Poul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Diabetes Technology Society 2008
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2769698/
https://ncbi.nlm.nih.gov/pubmed/19885176
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!